The test, called BinaxNOW, is produced by the health care company Abbott. The company is also launching an app that syncs up with the tests, and gives people who test negative for the virus a “digital health pass” that they can display on their phone. CEO Robert Ford said in a statement that the combination of the test and the app offer a “comprehensive testing solution.”

The company said in a press release that it plans to produce 50 million tests per month by October.

“Due to its simpler design and the large number of tests the company anticipates making in the coming months, this new antigen test is an important advancement in our fight against the pandemic,” said Jeff Shuren, director of the FDA Center for Devices and Radiological Health, in a statement.